Literature DB >> 17551933

CDG-Id in two siblings with partially different phenotypes.

Christian Kranz1, Liangwu Sun, Erik A Eklund, Donna Krasnewich, Janet R Casey, Hudson H Freeze.   

Abstract

We present two sibs with congenital disorder of glycosylation (CDG) type Id. Each shows severe global delay, failure to thrive, seizures, microcephaly, axial hypotonia, and disaccharidase deficiency. One sib has more severe digestive issues, while the other is more neurologically impaired. Each is compound heterozygous for a novel point mutation and an already known mutation in the ALG3 gene that leads to the synthesis of a severely truncated oligosaccharide precursor for N-glycans. The defect is corrected by introduction of a normal ALG3 cDNA. CDG should be ruled out in all patients with severe seizures and failure to thrive. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17551933     DOI: 10.1002/ajmg.a.31796

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  14 in total

Review 1.  Neurological aspects of human glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Annu Rev Neurosci       Date:  2015-04-02       Impact factor: 12.449

2.  ALG3-CDG: lethal phenotype and novel variants in Chinese siblings.

Authors:  Yue Bian; Chong Qiao; ShuGuang Zheng; Hao Qiu; Huan Li; ZhiTao Zhang; ShaoWei Yin; HongKun Jiang; Jesse Li-Ling; CaiXia Liu; Yuan Lyu
Journal:  J Hum Genet       Date:  2020-07-12       Impact factor: 3.172

3.  Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient.

Authors:  A Rimella-Le-Huu; H Henry; I Kern; S Hanquinet; E Roulet-Perez; C J Newman; A Superti-Furga; L Bonafé; D Ballhausen
Journal:  J Inherit Metab Dis       Date:  2008-08-09       Impact factor: 4.982

4.  Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.

Authors:  Ashwini Maratha; Hugh-Owen Colhoun; Ina Knerr; Karen P Coss; Peter Doran; Eileen P Treacy
Journal:  JIMD Rep       Date:  2016-08-09

Review 5.  Physiologic and pathophysiologic consequences of altered sialylation and glycosylation on ion channel function.

Authors:  Deniz Baycin-Hizal; Allan Gottschalk; Elena Jacobson; Sunny Mai; Daniel Wolozny; Hui Zhang; Sharon S Krag; Michael J Betenbaugh
Journal:  Biochem Biophys Res Commun       Date:  2014-06-24       Impact factor: 3.575

6.  Targeted polymerase chain reaction-based enrichment and next generation sequencing for diagnostic testing of congenital disorders of glycosylation.

Authors:  Melanie A Jones; Shruti Bhide; Ephrem Chin; Bobby G Ng; Devin Rhodenizer; Victor W Zhang; Jessica J Sun; Alice Tanner; Hudson H Freeze; Madhuri R Hegde
Journal:  Genet Med       Date:  2011-11       Impact factor: 8.822

7.  Successful treatment of intractable epilepsy with ketogenic diet therapy in twins with ALG3-CDG.

Authors:  C Paketci; P Edem; S Hiz; E Sonmezler; D Soydemir; G Sarikaya Uzan; Y Oktay; E O'Heir; S Beltran; S Laurie; A Töpf; H Lochmuller; R Horvath; U Yis
Journal:  Brain Dev       Date:  2020-05-07       Impact factor: 1.961

Review 8.  Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia.

Authors:  Yasmin Namavar; Peter G Barth; Bwee Tien Poll-The; Frank Baas
Journal:  Orphanet J Rare Dis       Date:  2011-07-12       Impact factor: 4.123

Review 9.  ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings.

Authors:  Martina Farolfi; Anna Cechova; Nina Ondruskova; Jana Zidkova; Bohdan Kousal; Hana Hansikova; Tomas Honzik; Petra Liskova
Journal:  BMC Ophthalmol       Date:  2021-06-05       Impact factor: 2.209

Review 10.  Hypoglycaemia related to inherited metabolic diseases in adults.

Authors:  Claire Douillard; Karine Mention; Dries Dobbelaere; Jean-Louis Wemeau; Jean-Marie Saudubray; Marie-Christine Vantyghem
Journal:  Orphanet J Rare Dis       Date:  2012-05-15       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.